Search by Drug Name or NDC
NDC 11527-0162-47 Sheffield Triple Antibiotic 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g Details
Sheffield Triple Antibiotic 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
Sheffield Triple Antibiotic is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Sheffield Pharmaceuticals LLC. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.
MedlinePlus Drug Summary
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
Related Packages: 11527-0162-47Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Neomycin, Polymyxin, and Bacitracin Topical
Product Information
| NDC | 11527-0162 |
|---|---|
| Product ID | 11527-162_3232162e-2200-4c52-b0d1-2424336733b2 |
| Associated GPIs | |
| GCN Sequence Number | 007694 |
| GCN Sequence Number Description | neomycin/bacitracin/polymyxinB OINT. (G) 3.5-400-5K TOPICAL |
| HIC3 | Q5W |
| HIC3 Description | TOPICAL ANTIBIOTICS |
| GCN | 85459 |
| HICL Sequence Number | 033356 |
| HICL Sequence Number Description | NEOMYCIN SULFATE/BACITRACIN ZINC/POLYMYXIN B |
| Brand/Generic | Brand |
| Proprietary Name | Sheffield Triple Antibiotic |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | OINTMENT |
| Route | TOPICAL |
| Active Ingredient Strength | 400; 3.5; 5000 |
| Active Ingredient Units | [USP'U]/g; mg/g; [USP'U]/g |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Labeler Name | Sheffield Pharmaceuticals LLC |
| Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M004 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 11527-0162-47 (11527016247)
| NDC Package Code | 11527-162-47 |
|---|---|
| Billing NDC | 11527016247 |
| Package | 1 TUBE in 1 CARTON (11527-162-47) / 9.35 g in 1 TUBE |
| Marketing Start Date | 2011-01-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |